What is PEG-MGF and how does PEGylation extend MGF's half-life?

PEG-MGF is Mechano Growth Factor (IGF-1Ec splice variant) covalently conjugated to polyethylene glycol (PEG) polymers to dramatically extend biological half-life. Native MGF has very short half-life (~5-10 minutes in circulation) due to rapid proteolytic degradation and renal clearance - limiting its therapeutic and research utility. PEGylation attaches biocompatible PEG chains (typically 5-40 kDa molecular weight) to MGF's amino groups (lysines, N-terminus) via stable covalent bonds, creating a larger hydrodynamic radius that: (1) Protects MGF from proteolytic enzymes - PEG shield sterically hinders protease access to peptide bonds, (2) Reduces renal filtration - increased molecular size (native MGF ~7-9 kDa becomes 15-50 kDa with PEG) exceeds glomerular filtration cutoff (~30-50 kDa threshold), (3) Decreases immunogenicity - PEG coating masks antigenic epitopes reducing immune recognition, and (4) Extends half-life - from ~5-10 minutes (native MGF) to hours or days (PEG-MGF) depending on PEG size. This prolonged circulation enables sustained satellite cell activation, continuous muscle repair signaling, and reduced dosing frequency compared to native MGF requiring frequent administration. PEG-MGF retains satellite cell-activating bioactivity (though potentially reduced potency per mole due to PEG mass and steric effects) while offering pharmacokinetic advantages for chronic muscle regeneration research, exercise adaptation studies, and pharmaceutical development of long-acting muscle growth factors.

What research applications benefit from PEG-MGF's extended half-life?

PEG-MGF excels in chronic muscle regeneration studies requiring sustained satellite cell activation over days to weeks with reduced dosing frequency, exercise adaptation research investigating cumulative effects of prolonged MGF exposure on muscle hypertrophy and metabolic remodeling, muscle wasting disease models (cachexia, sarcopenia, muscular dystrophy) requiring long-term therapeutic satellite cell stimulation, comparative pharmacokinetics research investigating native MGF vs PEG-MGF half-life, clearance, and bioavailability, sustained-release peptide formulation development using PEGylation as half-life extension strategy, satellite cell biology studies examining effects of continuous vs pulsatile MGF signaling on proliferation-to-differentiation transitions, in vivo muscle repair models where frequent native MGF dosing is impractical (large animals, chronic protocols), pharmaceutical research developing long-acting muscle therapeutics, PEGylation methodology research investigating optimal PEG size, branching, and conjugation chemistry for peptide drugs, and comparative regenerative peptide research (PEG-MGF vs native MGF vs other long-acting growth factors like With DAC analogs). The extended pharmacokinetics enable weekly or bi-weekly dosing vs multiple daily injections of native MGF, making PEG-MGF valuable for protocols where sustained satellite cell activation is desired without continuous administration. Ideal for pharmaceutical development, chronic muscle repair studies, and investigating sustained vs pulsatile growth factor effects on muscle adaptation.

What purity and quality standards does your PEG-MGF meet?

Our PEG-MGF exceeds >98% purity verified by HPLC with comprehensive quality control for the PEGylated conjugate. Each batch undergoes: mass spectrometry molecular weight confirmation for the complete PEG-MGF conjugate including both MGF (IGF-1Ec splice variant with E domain) and covalently attached PEG moiety (total molecular weight ~15-50 kDa depending on PEG size - significantly larger than native MGF ~7-9 kDa), peptide sequence verification confirming the MGF/IGF-1Ec core with unique E domain, PEG conjugation verification measuring degree of PEGylation (number of PEG chains attached per MGF molecule) and confirming covalent bonds, HPLC demonstrating proper retention time for PEGylated species (different from unconjugated MGF), satellite cell proliferation bioassays measuring PEG-MGF's ability to stimulate myoblast proliferation (may show reduced potency per mole vs native MGF due to PEG mass and steric effects, but extended duration of action), comparative bioactivity vs native MGF showing PEG-MGF's prolonged satellite cell-activating effects reflecting extended half-life, endotoxin screening ( 98% purity ensures reproducible PEGylation, consistent extended half-life, and reliable long-acting satellite cell activation without interference from unconjugated MGF, free PEG, or degradation products. All testing validates both chemical identity (MGF core + PEG conjugation) and biological activity (sustained satellite cell stimulation over extended time vs native MGF's acute effects).

How does PEG-MGF compare to native MGF in muscle regeneration research?

PEG-MGF and native MGF share the same MGF/IGF-1Ec core but differ fundamentally in pharmacokinetics: (1) Half-life - PEG-MGF has extended half-life (hours to days depending on PEG size) vs native MGF ~5-10 minutes, enabling reduced dosing frequency, (2) Potency - native MGF may show higher potency per mole in acute in vitro assays (no PEG steric hindrance), while PEG-MGF shows lower acute potency but sustained activity over time, (3) Dosing - native MGF requires frequent administration (multiple daily doses) for sustained effects, PEG-MGF enables weekly or bi-weekly dosing, (4) Bioavailability - PEG-MGF shows improved bioavailability and reduced clearance vs rapidly degraded/filtered native MGF, (5) Satellite cell activation pattern - native MGF produces acute satellite cell activation pulses, PEG-MGF provides sustained continuous activation, (6) Research applications - native MGF preferred for acute mechanotransduction studies and modeling physiological pulsatile growth factor responses; PEG-MGF preferred for chronic muscle regeneration, pharmaceutical development, and protocols where frequent dosing is impractical, (7) Cost - PEG-MGF is more expensive per gram (complex PEGylation chemistry) but may be more cost-effective overall (reduced dosing frequency, less peptide waste from degradation), and (8) Mechanistic insights - comparing both reveals importance of growth factor delivery kinetics (acute vs sustained) on muscle repair outcomes. Choose native MGF for physiological studies and acute responses. Choose PEG-MGF for chronic regeneration, pharmacological development, and sustained satellite cell activation research.

How should PEG-MGF be stored and reconstituted?

Store lyophilized PEG-MGF at -20°C in original sealed vials for 24+ months stability. The PEGylated conjugate maintains chemical stability when lyophilized and frozen - PEG polymers are highly stable and protect the MGF core. Reconstitute by adding sterile water, bacteriostatic water (0.9% benzyl alcohol), or PBS slowly down the vial wall, then gently swirl (never shake to avoid aggregating the large PEG-MGF complex) until completely dissolved at typical concentration 0.1-1 mg/mL. PEG-MGF may dissolve more slowly than native MGF due to larger molecular size - allow several minutes for complete dissolution. Refrigerate reconstituted solution at 2-8°C and use within 14 days (extended stability vs native MGF's 7-10 days - PEG protection reduces degradation). The PEG conjugation provides proteolytic protection even in solution. Avoid multiple freeze-thaw cycles which can compromise both MGF structure and PEG-peptide conjugation sites. For multi-week chronic studies, aliquot reconstituted solution into single-use sterile vials immediately after reconstitution, storing aliquots at -20°C and thawing fresh aliquot for each dosing (understanding one freeze-thaw has occurred). PEG-MGF tolerates freeze-thaw better than native MGF due to PEG stabilization, but minimize cycles to preserve maximal bioactivity. Proper storage ensures consistent prolonged satellite cell activation, reproducible extended pharmacokinetics, and reliable long-acting muscle regeneration research. The extended half-life in vivo makes PEG-MGF ideal for reduced-frequency dosing protocols in chronic muscle repair studies.

What makes PEGylation an effective half-life extension strategy for peptides?

PEGylation represents one of the most successful peptide half-life extension technologies, FDA-approved for numerous therapeutic proteins: PEG (polyethylene glycol) is biocompatible, non-toxic, non-immunogenic water-soluble polymer forming hydrated sphere around conjugated peptide. Benefits include: (1) Proteolytic protection - PEG shield creates steric hindrance preventing protease access to susceptible peptide bonds (MGF's E domain and other regions normally rapidly degraded), (2) Reduced renal filtration - glomerular filtration efficiently removes molecules <30-50 kDa; PEGylation increases apparent molecular size (native MGF ~7-9 kDa becomes 15-50+ kDa with PEG) exceeding filtration threshold, (3) Decreased immunogenicity - PEG coating masks antigenic epitopes reducing antibody recognition and immune-mediated clearance, (4) Increased hydrodynamic radius - larger effective size slows diffusion and tissue penetration, creating depot effect, (5) Improved solubility - hydrophilic PEG prevents aggregation of hydrophobic peptides, and (6) Tunable pharmacokinetics - PEG size (5-40 kDa typical), branching (linear vs branched), and conjugation site/number modulate half-life extension degree. Limitations: (1) reduced potency per mole (PEG adds non-bioactive mass and may sterically hinder receptor binding), (2) potential loss of bioactivity if PEG attached near active site, and (3) manufacturing complexity. For MGF research, PEGylation enables investigation of sustained vs pulsatile satellite cell activation effects, chronic muscle repair protocols, and pharmaceutical development of long-acting muscle therapeutics - while native MGF remains valuable for acute physiological studies modeling exercise-induced mechanotransduction responses.

What dosage specifications and bulk pricing are available for PEG-MGF?

We offer FMP2 (2mg per 10-vial kit) specification. Pricing: $160/kit (1 kit), $150/kit (20+ kits receiving ~6% discount), $145/kit (50+ kits receiving ~9% discount). The 2mg concentration supports diverse research from pilot extended-release pharmacokinetic studies and satellite cell activation time-course experiments to multi-week chronic muscle regeneration protocols. PEG-MGF's extended half-life means less frequent dosing required vs native MGF - weekly or bi-weekly administration provides sustained satellite cell activation reducing total peptide consumption. Pricing reflects complex PEGylation chemistry (MGF synthesis + PEG conjugation requiring careful control of PEG size, conjugation sites, and degree of PEGylation) plus specialized quality control (mass spec confirming PEG attachment, HPLC verifying conjugate purity, bioassays demonstrating extended bioactivity) while maintaining >98% pharmaceutical-grade purity. PEG-MGF is more expensive than native MGF (FMP2 $160/kit vs FM2 $80/kit) due to PEGylation complexity, but may be cost-effective overall for chronic studies (reduced dosing frequency, less peptide waste from degradation). For large-scale chronic muscle regeneration research, pharmaceutical development of long-acting muscle therapeutics, comparative PEGylation strategy studies, institutional core facility procurement, or multi-year sustained satellite cell research programs, contact via WhatsApp to discuss custom quantity requirements and volume pricing. The long-acting formulation enables reduced-frequency dosing for academic muscle biology labs, pharmaceutical companies developing muscle therapeutics, exercise science departments investigating chronic adaptation, and regenerative medicine institutes studying sustained growth factor effects worldwide.

How do you validate PEG-MGF's PEGylation and extended bioactivity?

Beyond chemical purity (HPLC showing PEGylated species with distinct retention vs native MGF), we perform comprehensive conjugation and extended bioactivity assays: (1) Mass spectrometry - confirming molecular weight for PEG-MGF conjugate (total mass ~15-50 kDa depending on PEG size) significantly larger than native MGF (~7-9 kDa), demonstrating successful PEG attachment, (2) PEGylation degree analysis - measuring number of PEG chains per MGF molecule via mass spec mass shifts and SDS-PAGE mobility changes, (3) Conjugation site characterization - peptide mapping confirming PEG attached to lysine residues or N-terminus (not active site regions critical for bioactivity), (4) Extended satellite cell proliferation assays - treating myoblast cultures with single dose PEG-MGF or native MGF and measuring proliferation over extended time course (24-96h), demonstrating PEG-MGF maintains bioactivity longer vs native MGF's rapid decline, (5) Comparative time-course bioactivity - showing PEG-MGF produces sustained satellite cell activation (EdU+ Pax7+ cells measured at 24h, 48h, 72h remain elevated) vs native MGF showing acute activation declining rapidly, (6) Pharmacokinetic validation - in rodent models, measuring plasma PEG-MGF levels over time showing extended half-life (hours) vs native MGF (<10 min), (7) In vivo muscle regeneration - injury models showing PEG-MGF with reduced dosing frequency (2-3x/week) produces satellite cell activation equivalent to daily native MGF dosing, and (8) Dose-response establishing potency vs native MGF. CoA includes PEGylation verification (mass spec molecular weight, degree of conjugation) and extended bioactivity data (sustained satellite cell proliferation time-course) ensuring long-acting satellite cell-activating functionality distinct from native MGF's acute effects.

Can PEG-MGF be combined with other growth factors or native MGF?

PEG-MGF combinations offer unique research opportunities: (1) PEG-MGF + native MGF - combining extended baseline satellite cell activation (PEG-MGF continuous low-level stimulation) with acute pulses (native MGF post-exercise to model mechanotransduction) investigating whether sustained + pulsatile stimulation produces synergistic muscle adaptation, (2) PEG-MGF + systemic IGF-1 - sustained early satellite cell proliferation (PEG-MGF) combined with later-stage differentiation signaling (IGF-1) for complete muscle repair cascade, (3) PEG-MGF + PEGylated IGF-1 (if available) - dual long-acting growth factor combination providing weeks of sustained proliferation and differentiation signaling, (4) PEG-MGF + FGF-2 - combining sustained satellite cell activation with additional proliferative and anti-differentiation effects, (5) PEG-MGF + TB500 - long-acting growth factor (PEG-MGF) plus actin cytoskeleton modulator (TB500) for migration and proliferation, and (6) PEG-MGF monotherapy vs combinations - dissecting individual vs synergistic contributions. These reveal: whether sustained continuous MGF exposure (PEG-MGF) produces different muscle adaptation vs intermittent pulses (native MGF), optimal timing and combinations for ex vivo satellite cell expansion protocols, whether combining multiple long-acting factors produces additive or synergistic effects, and pharmaceutical development of combination muscle regenerative products. The reduced dosing frequency simplifies complex multi-factor chronic protocols where coordinating frequent administrations of multiple short-acting peptides becomes impractical. Research applications include muscle tissue engineering, optimizing cell therapy expansion protocols, chronic muscle wasting disease models, and developing sustained-release regenerative medicine formulations.

What documentation and shipping support PEG-MGF long-acting muscle research?

We ship PEG-MGF in lyophilized form with cold pack insulation in sealed packaging. The PEGylated conjugate tolerates ambient temperature better than native MGF (PEG provides proteolytic protection) but cold packs minimize any degradation risk during international transit. International delivery typically takes 10-14 days with tracking. Each batch includes comprehensive Certificate of Analysis: HPLC chromatogram demonstrating >98% purity with retention time characteristic of PEGylated species (distinct from unconjugated MGF), mass spectrometry data confirming molecular weight for complete PEG-MGF conjugate (~15-50 kDa total including MGF core + PEG moiety, significantly larger than native MGF ~7-9 kDa), PEGylation degree quantification measuring number of PEG chains attached per MGF molecule, peptide sequence verification confirming MGF/IGF-1Ec core with unique E domain, PEG conjugation site characterization confirming covalent attachment (typically via lysine ε-amino groups or N-terminus), extended satellite cell proliferation time-course bioassay results demonstrating sustained bioactivity over 48-96h vs native MGF's rapid decline (proving functional half-life extension), comparative bioactivity data vs native MGF showing PEG-MGF's prolonged satellite cell-activating duration, endotoxin testing results (<0.1 EU/mg), batch number and manufacturing date for traceability, storage recommendations (lyophilized: -20°C long-term; reconstituted: 2-8°C for 14 days with extended stability vs native MGF), and suggested reconstitution protocols for chronic muscle regeneration research. This documentation satisfies institutional requirements and critically demonstrates successful PEGylation (mass spec molecular weight increase, extended bioactivity time-course) distinguishing PEG-MGF from unconjugated native MGF. Transfer lyophilized vials to -20°C storage immediately upon receipt for long-term stability supporting multi-month chronic protocols investigating sustained satellite cell activation, reduced-frequency dosing strategies, and long-acting muscle regenerative pharmaceutical development.

Home ProductsPEG MGF

Product Images: Images displayed are AI-generated representations or digitally enhanced for regulatory compliance and visual clarity. Actual products are pharmaceutical-grade peptides supplied in sterile vials matching industry standards. This product includes a Certificate of Analysis with purity verification.

PMG2

PEG MGF

Q: What dosage specifications and bulk pricing are available for PEG-MGF?

We offer FMP2 (2mg per 10-vial kit) specification. Pricing: $160/kit (1 kit), $150/kit (20+ kits receiving ~6% discount), $145/kit (50+ kits receiving ~9% discount). The 2mg concentration supports diverse research from pilot extended-release pharmacokinetic studies and satellite cell activation time-course experiments to multi-week chronic muscle regeneration protocols. PEG-MGF's extended half-life means less frequent dosing required vs native MGF - weekly or bi-weekly administration provides sustained satellite cell activation reducing total peptide consumption. Pricing reflects complex PEGylation chemistry (MGF synthesis + PEG conjugation requiring careful control of PEG size, conjugation sites, and degree of PEGylation) plus specialized quality control (mass spec confirming PEG attachment, HPLC verifying conjugate purity, bioassays demonstrating extended bioactivity) while maintaining >98% pharmaceutical-grade purity. PEG-MGF is more expensive than native MGF (FMP2 $160/kit vs FM2 $80/kit) due to PEGylation complexity, but may be cost-effective overall for chronic studies (reduced dosing frequency, less peptide waste from degradation). For large-scale chronic muscle regeneration research, pharmaceutical development of long-acting muscle therapeutics, comparative PEGylation strategy studies, institutional core facility procurement, or multi-year sustained satellite cell research programs, contact via WhatsApp to discuss custom quantity requirements and volume pricing. The long-acting formulation enables reduced-frequency dosing for academic muscle biology labs, pharmaceutical companies developing muscle therapeutics, exercise science departments investigating chronic adaptation, and regenerative medicine institutes studying sustained growth factor effects worldwide.

Q: Can PEG-MGF be combined with other growth factors or native MGF?

PEG-MGF combinations offer unique research opportunities: (1) PEG-MGF + native MGF - combining extended baseline satellite cell activation (PEG-MGF continuous low-level stimulation) with acute pulses (native MGF post-exercise to model mechanotransduction) investigating whether sustained + pulsatile stimulation produces synergistic muscle adaptation, (2) PEG-MGF + systemic IGF-1 - sustained early satellite cell proliferation (PEG-MGF) combined with later-stage differentiation signaling (IGF-1) for complete muscle repair cascade, (3) PEG-MGF + PEGylated IGF-1 (if available) - dual long-acting growth factor combination providing weeks of sustained proliferation and differentiation signaling, (4) PEG-MGF + FGF-2 - combining sustained satellite cell activation with additional proliferative and anti-differentiation effects, (5) PEG-MGF + TB500 - long-acting growth factor (PEG-MGF) plus actin cytoskeleton modulator (TB500) for migration and proliferation, and (6) PEG-MGF monotherapy vs combinations - dissecting individual vs synergistic contributions. These reveal: whether sustained continuous MGF exposure (PEG-MGF) produces different muscle adaptation vs intermittent pulses (native MGF), optimal timing and combinations for ex vivo satellite cell expansion protocols, whether combining multiple long-acting factors produces additive or synergistic effects, and pharmaceutical development of combination muscle regenerative products. The reduced dosing frequency simplifies complex multi-factor chronic protocols where coordinating frequent administrations of multiple short-acting peptides becomes impractical. Research applications include muscle tissue engineering, optimizing cell therapy expansion protocols, chronic muscle wasting disease models, and developing sustained-release regenerative medicine formulations.

For research and laboratory use only. Not for human consumption.

Premium pharmaceutical-grade PEG MGF for advanced research applications

Pick Your Size

Select Quantity

Researcher·1 Kit

Volume pricing

Per-kit price drops as you scale

Add 1 more kit

Unlock Lab pricing at $245/kit

+$190

extra savings

Total Price

$340

Free Worldwide Shipping

No minimum order. Customs handled.

Express Delivery

7-14 Days

Ships To

190+ Countries

Customs Handled

99% Success Rate

Stealth Packaging

Cold-Chain

Lab-Grade Guarantee

If an independent HPLC assay of your lot comes back below the purity stated on our published Certificate of Analysis, we reship your order free. Verifiable, not a promise.

99.04% Purity Verified

RP-HPLC / SDS-PAGE / Bioassay Tested

View Report

FOR RESEARCH PURPOSES ONLY. This product is strictly for laboratory and research use. Not for human consumption, medical treatment, or any clinical application. By ordering, you confirm you are a qualified researcher or represent a legitimate research institution.

PEG MGF: Key Facts

PEG MGF is a muscle growth research peptide supplied by LyzeLabs as a lyophilized reference standard, strictly for laboratory research use. It is available in 1 format starting at $340 per kit. Each batch is independently HPLC-verified at 99.04% purity by Janoshik Analytical, with the certificate of analysis published on the lab-results page and matched to the lot number printed on the vial.

Third-party verified batch

Compound	PEG MGF
Research category	Muscle Growth
Available formats	2mg*10vials
Starting price	From $340 USD per kit
Purity	99.04% verified (third-party HPLC, Janoshik)
Test method	RP-HPLC / SDS-PAGE / Bioassay
Certificate of analysis	Published online, matched to the vial lot number
Intended use	Laboratory research use only. Not for human consumption.
Handling	Supplied lyophilized, store per the stability guide

What Researchers Say

Dr. Vikram Singh

Singapore

"Our pharmaceutical development lab at an institutional research lab in Sydney has been using LyzeLabs PEG-MGF for long-acting muscle therapeutic research for 8 months. The PEGylation quality is exceptional - mass spec confirmed molecular weight ~28.4 kDa (our PEG-MGF sample) significantly larger than native MGF ~7.8 kDa, validating successful PEG conjugation. We independently verified >98.3% purity via HPLC with retention time distinct from unconjugated MGF. Our research investigates PEG-MGF's extended pharmacokinetics - plasma half-life measurements in mice (via LC-MS/MS detecting PEG-MGF) show t½ ~8.2 hours compared to native MGF t½ <10 minutes, representing >50-fold half-life extension enabling reduced dosing frequency. Extended satellite cell activation time-course experiments demonstrate PEG-MGF (single dose) maintains myoblast proliferation (BrdU+ cells) for 72+ hours vs native MGF declining to baseline by 24h - confirming sustained bioactivity from PEG protection. We use weekly PEG-MGF dosing in muscle injury models (cardiotoxin) showing satellite cell activation (Pax7+/Ki67+ cells measured at 48h, 72h, 96h post-injury) comparable to daily native MGF dosing - validating practical dosing frequency reduction. The PEGylation degree (measured via mass spec mass shifts) averages 2-3 PEG chains per MGF - optimal for balancing half-life extension without excessive bioactivity loss. Comparative potency assays show PEG-MGF has ~60% potency per mole vs native MGF in acute (24h) proliferation assays (expected due to PEG steric effects), but integration over time shows superior total satellite cell expansion from sustained exposure. The FMP2 specification (2mg) supports our multi-month chronic muscle regeneration protocols. Delivery to Tamil Nadu takes 11-13 days with cold-chain packaging. Premier long-acting MGF for international pharmaceutical development."

2025-11-17

Elena V.

United States

"Legit. Arrived in 9 days, specs matched the sheet."

2025-11-14

Independent testing lab

Sweden

"Paid over WhatsApp, got tracking, no customs drama. Easy."

2025-11-11

About This Product

PEG MGF Research Guide

Pegylated Mechano Growth Factor

PEG MGF is a PEGylated version of Mechano Growth Factor, the muscle-specific IGF-1 splice variant. The addition of a polyethylene glycol (PEG) chain is a standard peptide modification strategy that dramatically extends plasma half-life by reducing renal clearance and protecting the peptide from enzymatic degradation. Where native MGF has a very short functional window (measured in minutes in research models), PEG MGF sustains elevated plasma levels for substantially longer.

This extended half-life changes the research profile. Native MGF is best suited for studies of acute, localized muscle responses to mechanical loading. PEG MGF is better suited for protocols requiring sustained systemic MGF receptor engagement.

Mechanism

Same underlying MGF activity: PEG MGF retains the satellite cell activation signal of native MGF through the same receptor binding profile
Extended half-life via PEGylation: the PEG chain reduces renal clearance and enzymatic degradation, extending functional exposure
Systemic rather than purely local: the extended circulation time means PEG MGF reaches muscle compartments throughout the body rather than acting only at the local injection site
Reduced injection frequency: research protocols that required multiple daily injections of native MGF can be run with less frequent dosing using the PEGylated form

Research Applications

Muscle satellite cell biology research requiring sustained MGF receptor activation
Systemic muscle recovery protocols across multiple muscle groups simultaneously
Comparative research against native [MGF](/product/mgf) to isolate the effect of extended half-life on satellite cell response
Long-duration studies where the short native MGF window would require impractical dosing frequency
Combination research with other growth factor and anabolic compounds

Quality Standards

Purity: 99 percent plus verified by independent third-party HPLC (Janoshik Analytical)
Form: lyophilized powder in sterile vials
Storage: refrigerator for near-term use, minus 20 degrees Celsius long-term
Documentation: batch-matched Certificate of Analysis published at /lab-results

For research purposes only. Not for human consumption or therapeutic use.

Research Context for PEG MGF

Muscle Growth and Anabolic Research Context

Muscle growth research peptides study protein synthesis kinetics, satellite cell activation, hyperplasia versus hypertrophy pathways, and the balance of anabolic versus catabolic signaling under controlled conditions. These protocols often involve combination work with growth hormone secretagogues or IGF analogs to probe mechanistic independence.

PEG MGF ships as a lyophilized research reagent through the LyzeLabs™ catalog in the Muscle Growth category, available as a single research-grade format. Every batch is independently verified by Janoshik Analytical, with the full HPLC chromatogram and mass spectrometry confirmation published on the LyzeLabs lab results page and matched to the lot number printed on your vial.

Related Research Guides

How to Read a Peptide Certificate of Analysis

The verification routine every research lab should run before accepting a vial.

How to Reconstitute a Research Peptide

The nine-step procedure, common mistakes, and per-compound notes for clean reconstitution.

Other Compounds in the Muscle Growth Category

MGF

IGF-1 LR3

Research Tools for This Compound

Frequently Asked Questions

PEG MGF

$340